The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Single Cell Genomics-Global Market Insights and Sales Trends 2024
Synopsis
Single-cell genomics is the study of the individuality of cells using omics approaches.
The global Single Cell Genomics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Single Cell Genomics in various end use industries. The expanding demands from the Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells and Cell Differentiation, are propelling Single Cell Genomics market. Cell Isolation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sample Preparation segment is estimated at % CAGR for the next seven-year period.
North America is the dominating region in the single cell genomics market owing to the advancing biopharmaceutical and biotechnology and genomics field.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single Cell Genomics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single Cell Genomics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single Cell Genomics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single Cell Genomics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single Cell Genomics covered in this report include 10X Genomics, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics, Denovo Sciences, DNA Electronics, Enumeral Biomedical and Epic Sciences, etc.
The global Single Cell Genomics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
10X Genomics
Accelerate Diagnostics
Affymetrix
Agilent Technologies
Celsee Diagnostics
Denovo Sciences
DNA Electronics
Enumeral Biomedical
Epic Sciences
Kellbenx
Qiagen
Resolution Bioscience
Thermo Fisher Scientific
Wafergen Bio-Systems
Yikon Genomics
Zephyrus Biosciences
Global Single Cell Genomics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single Cell Genomics market, Segment by Type:
Cell Isolation
Sample Preparation
Genomic Analysis
Global Single Cell Genomics market, by Application
Genomic Variation
Subpopulation Characterization
Circulating Tumor Cells
Cell Differentiation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single Cell Genomics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Single-cell genomics is the study of the individuality of cells using omics approaches.
The global Single Cell Genomics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Single Cell Genomics in various end use industries. The expanding demands from the Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells and Cell Differentiation, are propelling Single Cell Genomics market. Cell Isolation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sample Preparation segment is estimated at % CAGR for the next seven-year period.
North America is the dominating region in the single cell genomics market owing to the advancing biopharmaceutical and biotechnology and genomics field.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single Cell Genomics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single Cell Genomics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single Cell Genomics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single Cell Genomics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single Cell Genomics covered in this report include 10X Genomics, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics, Denovo Sciences, DNA Electronics, Enumeral Biomedical and Epic Sciences, etc.
The global Single Cell Genomics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
10X Genomics
Accelerate Diagnostics
Affymetrix
Agilent Technologies
Celsee Diagnostics
Denovo Sciences
DNA Electronics
Enumeral Biomedical
Epic Sciences
Kellbenx
Qiagen
Resolution Bioscience
Thermo Fisher Scientific
Wafergen Bio-Systems
Yikon Genomics
Zephyrus Biosciences
Global Single Cell Genomics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single Cell Genomics market, Segment by Type:
Cell Isolation
Sample Preparation
Genomic Analysis
Global Single Cell Genomics market, by Application
Genomic Variation
Subpopulation Characterization
Circulating Tumor Cells
Cell Differentiation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single Cell Genomics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Single Cell Genomics
1.1 Single Cell Genomics Market Overview
1.1.1 Single Cell Genomics Product Scope
1.1.2 Single Cell Genomics Market Status and Outlook
1.2 Global Single Cell Genomics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Single Cell Genomics Market Size by Region (2018-2029)
1.4 Global Single Cell Genomics Historic Market Size by Region (2018-2023)
1.5 Global Single Cell Genomics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Single Cell Genomics Market Size (2018-2029)
1.6.1 North America Single Cell Genomics Market Size (2018-2029)
1.6.2 Europe Single Cell Genomics Market Size (2018-2029)
1.6.3 Asia-Pacific Single Cell Genomics Market Size (2018-2029)
1.6.4 Latin America Single Cell Genomics Market Size (2018-2029)
1.6.5 Middle East & Africa Single Cell Genomics Market Size (2018-2029)
2 Single Cell Genomics Market by Type
2.1 Introduction
2.1.1 Cell Isolation
2.1.2 Sample Preparation
2.1.3 Genomic Analysis
2.2 Global Single Cell Genomics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Single Cell Genomics Historic Market Size by Type (2018-2023)
2.2.2 Global Single Cell Genomics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Single Cell Genomics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Single Cell Genomics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Single Cell Genomics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Single Cell Genomics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Single Cell Genomics Revenue Breakdown by Type (2018-2029)
3 Single Cell Genomics Market Overview by Application
3.1 Introduction
3.1.1 Genomic Variation
3.1.2 Subpopulation Characterization
3.1.3 Circulating Tumor Cells
3.1.4 Cell Differentiation
3.1.5 Others
3.2 Global Single Cell Genomics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Single Cell Genomics Historic Market Size by Application (2018-2023)
3.2.2 Global Single Cell Genomics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Single Cell Genomics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Single Cell Genomics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Single Cell Genomics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Single Cell Genomics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Single Cell Genomics Revenue Breakdown by Application (2018-2029)
4 Single Cell Genomics Competition Analysis by Players
4.1 Global Single Cell Genomics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single Cell Genomics as of 2022)
4.3 Date of Key Players Enter into Single Cell Genomics Market
4.4 Global Top Players Single Cell Genomics Headquarters and Area Served
4.5 Key Players Single Cell Genomics Product Solution and Service
4.6 Competitive Status
4.6.1 Single Cell Genomics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 10X Genomics
5.1.1 10X Genomics Profile
5.1.2 10X Genomics Main Business
5.1.3 10X Genomics Single Cell Genomics Products, Services and Solutions
5.1.4 10X Genomics Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.1.5 10X Genomics Recent Developments
5.2 Accelerate Diagnostics
5.2.1 Accelerate Diagnostics Profile
5.2.2 Accelerate Diagnostics Main Business
5.2.3 Accelerate Diagnostics Single Cell Genomics Products, Services and Solutions
5.2.4 Accelerate Diagnostics Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.2.5 Accelerate Diagnostics Recent Developments
5.3 Affymetrix
5.3.1 Affymetrix Profile
5.3.2 Affymetrix Main Business
5.3.3 Affymetrix Single Cell Genomics Products, Services and Solutions
5.3.4 Affymetrix Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.3.5 Agilent Technologies Recent Developments
5.4 Agilent Technologies
5.4.1 Agilent Technologies Profile
5.4.2 Agilent Technologies Main Business
5.4.3 Agilent Technologies Single Cell Genomics Products, Services and Solutions
5.4.4 Agilent Technologies Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.4.5 Agilent Technologies Recent Developments
5.5 Celsee Diagnostics
5.5.1 Celsee Diagnostics Profile
5.5.2 Celsee Diagnostics Main Business
5.5.3 Celsee Diagnostics Single Cell Genomics Products, Services and Solutions
5.5.4 Celsee Diagnostics Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.5.5 Celsee Diagnostics Recent Developments
5.6 Denovo Sciences
5.6.1 Denovo Sciences Profile
5.6.2 Denovo Sciences Main Business
5.6.3 Denovo Sciences Single Cell Genomics Products, Services and Solutions
5.6.4 Denovo Sciences Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.6.5 Denovo Sciences Recent Developments
5.7 DNA Electronics
5.7.1 DNA Electronics Profile
5.7.2 DNA Electronics Main Business
5.7.3 DNA Electronics Single Cell Genomics Products, Services and Solutions
5.7.4 DNA Electronics Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.7.5 DNA Electronics Recent Developments
5.8 Enumeral Biomedical
5.8.1 Enumeral Biomedical Profile
5.8.2 Enumeral Biomedical Main Business
5.8.3 Enumeral Biomedical Single Cell Genomics Products, Services and Solutions
5.8.4 Enumeral Biomedical Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.8.5 Enumeral Biomedical Recent Developments
5.9 Epic Sciences
5.9.1 Epic Sciences Profile
5.9.2 Epic Sciences Main Business
5.9.3 Epic Sciences Single Cell Genomics Products, Services and Solutions
5.9.4 Epic Sciences Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.9.5 Epic Sciences Recent Developments
5.10 Kellbenx
5.10.1 Kellbenx Profile
5.10.2 Kellbenx Main Business
5.10.3 Kellbenx Single Cell Genomics Products, Services and Solutions
5.10.4 Kellbenx Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.10.5 Kellbenx Recent Developments
5.11 Qiagen
5.11.1 Qiagen Profile
5.11.2 Qiagen Main Business
5.11.3 Qiagen Single Cell Genomics Products, Services and Solutions
5.11.4 Qiagen Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.11.5 Qiagen Recent Developments
5.12 Resolution Bioscience
5.12.1 Resolution Bioscience Profile
5.12.2 Resolution Bioscience Main Business
5.12.3 Resolution Bioscience Single Cell Genomics Products, Services and Solutions
5.12.4 Resolution Bioscience Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.12.5 Resolution Bioscience Recent Developments
5.13 Thermo Fisher Scientific
5.13.1 Thermo Fisher Scientific Profile
5.13.2 Thermo Fisher Scientific Main Business
5.13.3 Thermo Fisher Scientific Single Cell Genomics Products, Services and Solutions
5.13.4 Thermo Fisher Scientific Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.13.5 Thermo Fisher Scientific Recent Developments
5.14 Wafergen Bio-Systems
5.14.1 Wafergen Bio-Systems Profile
5.14.2 Wafergen Bio-Systems Main Business
5.14.3 Wafergen Bio-Systems Single Cell Genomics Products, Services and Solutions
5.14.4 Wafergen Bio-Systems Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.14.5 Wafergen Bio-Systems Recent Developments
5.15 Yikon Genomics
5.15.1 Yikon Genomics Profile
5.15.2 Yikon Genomics Main Business
5.15.3 Yikon Genomics Single Cell Genomics Products, Services and Solutions
5.15.4 Yikon Genomics Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.15.5 Yikon Genomics Recent Developments
5.16 Zephyrus Biosciences
5.16.1 Zephyrus Biosciences Profile
5.16.2 Zephyrus Biosciences Main Business
5.16.3 Zephyrus Biosciences Single Cell Genomics Products, Services and Solutions
5.16.4 Zephyrus Biosciences Single Cell Genomics Revenue (US$ Million) & (2018-2023)
5.16.5 Zephyrus Biosciences Recent Developments
6 North America
6.1 North America Single Cell Genomics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Single Cell Genomics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Genomics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Single Cell Genomics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Genomics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Single Cell Genomics Market Dynamics
11.1 Single Cell Genomics Industry Trends
11.2 Single Cell Genomics Market Drivers
11.3 Single Cell Genomics Market Challenges
11.4 Single Cell Genomics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
